Compare ASND & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASND | GNRC |
|---|---|---|
| Founded | 2006 | 1959 |
| Country | Denmark | United States |
| Employees | N/A | 9400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 11.8B |
| IPO Year | 2014 | N/A |
| Metric | ASND | GNRC |
|---|---|---|
| Price | $241.40 | $264.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 17 |
| Target Price | ★ $281.50 | $211.75 |
| AVG Volume (30 Days) | 705.5K | ★ 759.4K |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $96.35 | $17.36 |
| Revenue Next Year | $44.91 | $12.51 |
| P/E Ratio | ★ N/A | $84.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $153.49 | $118.09 |
| 52 Week High | $250.74 | $275.55 |
| Indicator | ASND | GNRC |
|---|---|---|
| Relative Strength Index (RSI) | 54.49 | 64.79 |
| Support Level | $215.18 | $198.21 |
| Resistance Level | $249.87 | N/A |
| Average True Range (ATR) | 9.62 | 9.43 |
| MACD | 1.30 | 0.73 |
| Stochastic Oscillator | 71.91 | 81.57 |
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.